Details
Stereochemistry | RACEMIC |
Molecular Formula | C6H8FN3O3 |
Molecular Weight | 188.147 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(C[18F])CN1C=CN=C1[N+]([O-])=O
InChI
InChIKey=HIIJZYSUEJYLMX-JZRMKITLSA-N
InChI=1S/C6H8FN3O3/c7-3-5(11)4-9-2-1-8-6(9)10(12)13/h1-2,5,11H,3-4H2/i7-1
Molecular Formula | C6H8FN3O3 |
Molecular Weight | 188.147 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Fluoromisonidazole F-18 ([F-18] FMISO) is used as a positron emission tomography (PET) radiotracer for imaging. It is generated by labeling fluoromisonidazole with fluorine-18. It is the most widely used nitroimidazole imaging agent for use as a non-invasive way to localize and quantify hypoxia. [18F] decays by positron emission. FMISO binds covalently to cellular molecules at rates that are inversely proportional to intracellular oxygen concentration. In hypoxic cells, FMISO is trapped, which is the basis for the use of this tracer to measure hypoxia.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times. | 2016 Mar |
|
(18)F-Fluoromisonidazole in tumor hypoxia imaging. | 2017 Nov 7 |
|
(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model. | 2018 Jun 18 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:22 GMT 2023
by
admin
on
Fri Dec 15 15:42:22 GMT 2023
|
Record UNII |
8MSY49469G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
521116
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
||
|
FDA ORPHAN DRUG |
509715
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14830
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
100000168508
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
FMISO
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
DTXSID801313634
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
450173
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
8MSY49469G
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
SUB182026
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
104613-87-8
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY | |||
|
C52180
Created by
admin on Fri Dec 15 15:42:22 GMT 2023 , Edited by admin on Fri Dec 15 15:42:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
STARTING MATERIAL -> INGREDIENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |